These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 35469617)

  • 81. Impact of excipient interactions on solid dosage form stability.
    Narang AS; Desai D; Badawy S
    Pharm Res; 2012 Oct; 29(10):2660-83. PubMed ID: 22707362
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Medicines containing pharmaceutical excipients with known effects: a French review.
    Fusier I; Tollier C; Husson MC
    Pharm World Sci; 2003 Aug; 25(4):152-5. PubMed ID: 12964493
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates.
    Shehab N; Lewis CL; Streetman DD; Donn SM
    Pediatr Crit Care Med; 2009 Mar; 10(2):256-9. PubMed ID: 19188870
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Evaluation of Excipient Risk in BCS Class I and III Biowaivers.
    Metry M; Polli JE
    AAPS J; 2022 Jan; 24(1):20. PubMed ID: 34988701
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Biopharmaceutical aspects and implications of excipient variability in drug product performance.
    Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
    Eur J Pharm Biopharm; 2017 Feb; 111():1-15. PubMed ID: 27845182
    [TBL] [Abstract][Full Text] [Related]  

  • 86. World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base.
    Simons FE; Ardusso LR; Dimov V; Ebisawa M; El-Gamal YM; Lockey RF; Sanchez-Borges M; Senna GE; Sheikh A; Thong BY; Worm M;
    Int Arch Allergy Immunol; 2013; 162(3):193-204. PubMed ID: 24008815
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Anaphylaxis to drugs.
    Kuruvilla M; Khan DA
    Immunol Allergy Clin North Am; 2015 May; 35(2):303-19. PubMed ID: 25841553
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Study on selecting the suitable solubilizing excipients for Shengmai injection].
    Zhang SF; Yan D; Tang HY; Li HB; Wang YS; Xiao XH; Yang M
    Zhong Yao Cai; 2009 Jun; 32(6):969-72. PubMed ID: 19764337
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Anaphylaxis.
    Yunginger JW
    Ann Allergy; 1992 Aug; 69(2):87-96. PubMed ID: 1510292
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Studies on the food allergenic proteins contained in pharmaceutical excipients].
    Sakai S; Adachi R; Miyazaki T; Aso Y; Okuda H; Teshima R
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2012; (130):58-65. PubMed ID: 23243989
    [TBL] [Abstract][Full Text] [Related]  

  • 91. An Overview of Pharmaceutical Excipients: Safe or Not Safe?
    Abrantes CG; Duarte D; Reis CP
    J Pharm Sci; 2016 Jul; 105(7):2019-26. PubMed ID: 27262205
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Choosing a medication brand: Excipients, food intolerance and prescribing in older people.
    Page A; Etherton-Beer C
    Maturitas; 2018 Jan; 107():103-109. PubMed ID: 29169573
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The diagnosis and management of anaphylaxis. Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology.
    J Allergy Clin Immunol; 1998 Jun; 101(6 Pt 2):S465-528. PubMed ID: 9673591
    [No Abstract]   [Full Text] [Related]  

  • 94. An Elemental Impurities Excipient Database: A Viable Tool for ICH Q3D Drug Product Risk Assessment.
    Boetzel R; Ceszlak A; Day C; Drumm P; Gil Bejar J; Glennon J; Harris L; Heghes CI; Horga R; Jacobs PL; Keurentjes WJTM; King F; Lee CW; Lewen N; Marchant CA; Maris FA; Nye W; Powell S; Rockstroh H; Rutter L; Schweitzer M; Shannon E; Smallshaw L; Teasdale A; Thompson S; Wilkinson D
    J Pharm Sci; 2018 Sep; 107(9):2335-2340. PubMed ID: 29679706
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Nitrosated Active Pharmaceutical Ingredients - Lessons Learned?
    Holzgrabe U
    J Pharm Sci; 2023 May; 112(5):1210-1215. PubMed ID: 36720391
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse.
    Moench TR; Mumper RJ; Hoen TE; Sun M; Cone RA
    BMC Infect Dis; 2010 Nov; 10():331. PubMed ID: 21087496
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Anaphylactic reaction to intralesional corticosteroid injection.
    Laing ME; Fallis B; Murphy GM
    Contact Dermatitis; 2007 Aug; 57(2):132-3. PubMed ID: 17627664
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Contact urticaria with systemic symptoms due to hexylene glycol in a topical corticosteroid: case report and review of hypersensitivity to glycols.
    Spoerl D; Scherer K; Bircher AJ
    Dermatology; 2010; 220(3):238-42. PubMed ID: 20185893
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Recognition and Management of Medication Excipient Reactivity in Patients With Mast Cell Activation Syndrome.
    Schofield JR; Afrin LB
    Am J Med Sci; 2019 Jun; 357(6):507-511. PubMed ID: 31126513
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A patient with an allergy emergency.
    Houser SM; Weng C; Liu YC
    JAMA Otolaryngol Head Neck Surg; 2015 Apr; 141(4):382-5. PubMed ID: 25675291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.